All In Biotech

Drug Trial Radar · NCT06471543

Study of RN0361in Adult Healthy Subjects and Adult Hypertriglyceridemic Subjects

A Phase 1, Randomized, Placebo-controlled, Single Ascending Dose and Phase 2 Randomized, Placebo Controlled, Parallel-Group, Single-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamic Effects, and Immunogenicity of RN0361 in Adult Healthy Subjects and Hypertriglyceridemic Subjects

Last checked: Nov 19, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 108 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

108

Actual

Start

Sep 30, 2024

Primary completion

Jun 3, 2026

Study completion Aug 25, 2026

Sponsor

Lead sponsor
Ikaria Bioscience Pty LtdIndustry
Sponsor type
Industry
First posted
Jun 24, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and immunogenicity of single doses of RN0361 in Adult healthy subjects and Adult Hypertriglyceridemic Subjects.

Conditions

  • Hypertriglyceridemia
  • Familial Chylomicronemia Syndrome

Interventions

  • RN0361Drug

    Placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number and incidence of adverse events (AEs)/serious adverse events (SAEs) possibly or probably related to treatment of RN0361 in adult healthy subjects.Time frame: Up to Day85
  2. Absolute and percent change from baseline in APOC3 and fasting triglycerides (TG) in subjects with HTGTime frame: Up to Day183

Locations

10 sites in 2 countries. Site status is shown where the registry gives one.

  • TBC Research LLC,

    Tamarac, Florida

  • Versailles Family Medicine / Avacare

    Versailles, Kentucky

  • Axis Clinicals USA

    Dilworth, Minnesota

  • Synergy Groups Medical

    Houston, Texas

  • Tranquil

    Webster, Texas

  • Ogden Clinic, Mountain View / Avacare

    Pleasant View, Utah

  • University of the Sunshine Coast Clinical Trials

    Morayfield, Queensland, Australia

  • University of the Sunshine Coast Clinical Trials, Sippy Downs

    Sippy Downs, Queensland, Australia

  • Altona Clinical Research

    Altona N., Victoria, Australia

  • Nucleus Network Melbourne

    Melbourne, Victoria, Australia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.